Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information


EU orphan designation number: EU/3/13/1194   
Active ingredient: Naproxcinod
Indication: Treatment of Duchenne muscular dystrophy
Sponsor: NicOx
Drakkar 2- Bat D, 2405 route des Dolines, CS 10313 Sophia Antipolis, 06560 Valbonne, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
09/10/2013 Orphan designation EMA/OD/090/13 (2013)6739 of 07/10/2013